Abbott Laboratories
NYSE:ABT

Watchlist Manager
Abbott Laboratories Logo
Abbott Laboratories
NYSE:ABT
Watchlist
Price: 117.76 USD 0.43% Market Closed
Market Cap: 204.3B USD
Have any thoughts about
Abbott Laboratories?
Write Note

Abbott Laboratories
Net Income (Common)

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Abbott Laboratories
Net Income (Common) Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Net Income (Common) CAGR 3Y CAGR 5Y CAGR 10Y
Abbott Laboratories
NYSE:ABT
Net Income (Common)
$5.8B
CAGR 3-Years
-7%
CAGR 5-Years
12%
CAGR 10-Years
11%
Becton Dickinson and Co
NYSE:BDX
Net Income (Common)
$1.7B
CAGR 3-Years
-5%
CAGR 5-Years
10%
CAGR 10-Years
4%
Boston Scientific Corp
NYSE:BSX
Net Income (Common)
$1.8B
CAGR 3-Years
18%
CAGR 5-Years
10%
CAGR 10-Years
20%
Edwards Lifesciences Corp
NYSE:EW
Net Income (Common)
$4.2B
CAGR 3-Years
41%
CAGR 5-Years
40%
CAGR 10-Years
18%
Stryker Corp
NYSE:SYK
Net Income (Common)
$3.6B
CAGR 3-Years
24%
CAGR 5-Years
1%
CAGR 10-Years
19%
Intuitive Surgical Inc
NASDAQ:ISRG
Net Income (Common)
$2.2B
CAGR 3-Years
10%
CAGR 5-Years
11%
CAGR 10-Years
18%
No Stocks Found

Abbott Laboratories
Glance View

Market Cap
204.9B USD
Industry
Health Care

Abbott Laboratories, a global leader in the healthcare industry, has a storied history dating back to its founding in 1888 by Dr. Wallace Abbott. The company is renowned for its dedication to improving health through innovative products that span several key segments: diagnostics, medical devices, nutrition, and branded generic pharmaceuticals. With a robust portfolio that includes cutting-edge technologies such as continuous glucose monitoring systems and rapid COVID-19 tests, Abbott has positioned itself as a vital player in both consumer and professional healthcare arenas. Its commitment to research and development, capturing nearly $2 billion in annual investment, underscores the company's strategic focus on innovation and long-term growth, making it an attractive option for investors seeking stability and upward trajectory in the healthcare sector. Abbott's diverse product offerings and strong market presence provide a solid foundation for its financial performance, which has consistently demonstrated resilience and growth across economic cycles. The company's ability to adapt to changing healthcare needs—exemplified by its rapid response to the COVID-19 pandemic with the development of at-home testing solutions—highlights its proactive approach and operational agility. In addition to its impressive revenue streams, Abbott pays a growing dividend, appealing to income-focused investors. With a clear vision for the future, bolstered by global expansion and strategic acquisitions, Abbott Laboratories is not just a company that manufactures healthcare products; it is a catalyst for positive change in health and well-being, making it a compelling investment opportunity for those looking to capitalize on the ever-evolving healthcare landscape.

ABT Intrinsic Value
100.13 USD
Overvaluation 15%
Intrinsic Value
Price

See Also

What is Abbott Laboratories's Net Income (Common)?
Net Income (Common)
5.8B USD

Based on the financial report for Sep 30, 2024, Abbott Laboratories's Net Income (Common) amounts to 5.8B USD.

What is Abbott Laboratories's Net Income (Common) growth rate?
Net Income (Common) CAGR 10Y
11%

Over the last year, the Net Income (Common) growth was 12%. The average annual Net Income (Common) growth rates for Abbott Laboratories have been -7% over the past three years , 12% over the past five years , and 11% over the past ten years .

Back to Top